Stephanie Okey, Director at Albireo Pharma, holds ― shares in Albireo Pharma (Ticker: ALBO), holds 12.63K shares in Catalent (Ticker: CTLT), holds 9.40K shares in Crinetics Pharmaceuticals (Ticker: CRNX). Most recently, Stephanie Okey ― shares of Albireo Pharma on ― for an estimated value of ―.
Stephanie Okey latest transaction was an Uninformative Buy of ―.
What was Stephanie Okey's most profitable transaction?
Stephanie Okey’s most profitable transaction was an Informative Sell of PTCT stock on August 11, 2022. The return on the trade was 19.80%.
What is Stephanie Okey's role in Albireo Pharma?
Stephanie Okey's role in Albireo Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.